The Filing Desk

Orchestra BioMed vs Senseonics

Orchestra BioMed OBIO · Senseonics SENS · Health Care Equipment

Senseonics reported revenue of $35 million in fiscal 2025, about the same as Orchestra BioMed's $34 million in fiscal 2025. Orchestra BioMed's revenue grew 1169.2% in its latest year, and Senseonics' grew 56.9%. Orchestra BioMed had an operating margin of -154.7%, against -193.8% at Senseonics. Free cash flow was −$49 million at Orchestra BioMed and −$60 million at Senseonics.

Side by side

Orchestra BioMedSenseonics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$34M$35M
Revenue growth1,169.2%56.9%
Revenue growth a year, last 5 years—48.4%
Gross margin99.4%44.7%
Operating margin−154.7%−193.8%
Net margin−157.4%−196.0%
Free cash flow−$49M−$60M
Free cash flow margin−147.7%−170.9%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count29.7%32.5%
Last close$7.00$8.90
P/E at the last close——
Insider trades, last 12 monthsbought $259,541, sold $257,682bought $627,302, sold $0
Piotroski F-score5 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Orchestra BioMedSenseonics
Operating margin
Percent of revenue
Orchestra BioMedSenseonics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Orchestra BioMedSenseonics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Orchestra BioMed and Senseonics pages.